Displaying drugs 2451 - 2475 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Gamolenic acid | 278.4296 C18H30O2 |  | An ingredient found in a variety of nutritional products. | Fatty Acids, Omega-6 / Linolenic Acids |
| Dimazole | 293.43 C15H23N3OS |  | Dimazole (diamthazole) is an antifungal. It was withdrawn in Franch in 1972 due to neuropsychiatric reactions. | Antifungals for Dermatological Use / Antifungals for Topical Use / Dermatologicals / Sulfur Compounds |
| Fluticasone | 444.51 C22H27F3O4S |  | A corticosteroid indicated in the treatment of corticosteroid responsive dermatoses, asthma, and COPD. | Corticosteroids, Potent (Group III) / Glucocorticoids |
| Lormetazepam | 335.185 C16H12Cl2N2O2 |  | A benzodiazepine indicated in the treatment of anxiety and the induction of anesthesia. | Benzodiazepines and benzodiazepine derivatives |
| Fenofibric acid | 318.75 C17H15ClO4 |  | A fibrate used to treat severe hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. | Fibric Acids |
| Enasidenib | 473.383 C19H17F6N7O |  | An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. | Isocitrate Dehydrogenase 2 Inhibitor |
| Pibrentasvir | 1113.201 C57H65F5N10O8 |  | A Hepatitis C NS5A inhibitor used to treat Hepatitis C. | Antivirals for treatment of HCV infections |
| Glecaprevir | 838.87 C38H46F4N6O9S |  | A Hepatitis C NS3/4A protease inhibitor used to treat Hepatitis C. | Antivirals for treatment of HCV infections |
| Methyl nicotinate | 137.136 C7H7NO2 |  | A methyl ester of niacin used to treat muscle and joint pain. | Anti-Inflammatory Agents / Erythema / Inflammation / Nicotinic Acids |
| Ferric subsulfate | Not Annotated |  | Ferric subsulfate is a stypic or hemostatic agent that causes agglutination of surface proteins resulting in local hemostasis. It has the chemical formula Fe4(OH)2(SO4)5. It is used after superficial skin... | Hemostatics |
| Amylmetacresol | 178.275 C12H18O |  | An antiseptic used to treat infections in the mouth and throat. | Anti-Infective Agents, Local / Benzene Derivatives / Miscellaneous Anti-infectives / Phenols |
| Bismuth subgallate | 394.091 C7H5BiO6 |  | A medication used to deodorize flatulence and stools as well as hemostasis in soft tissue surgery. | Neurotoxic agents |
| Valproate bismuth | 638.598 C24H45BiO6 |  | A medication used to treat laryngitis. | Neurotoxic agents |
| Phloxine B | 829.63 C20H2Br4Cl4Na2O5 |  | For use in dental disclosing products, allowing for highlighting of bacterial placques. | Fluoresceins / Fluorescent Dyes |
| Dotatate gallium Ga-68 | 1500.54 C65H87GaN14O19S2 |  | Dotatate gallium 68 is one of the most prominent radiopharmaceuticals used in imaging with positron emission tomography. It binds to the somatostatin-2 receptor which is usually overexpressed in many neuroendocrine... | Gallium Radioisotopes / Radioactive Diagnostic Agent |
| Semaglutide | 4113.641 C187H291N45O59 |  | A glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults. | Glucagon-like peptide-1 (GLP-1) analogues |
| Netarsudil | 453.542 C28H27N3O3 |  | A rho kinase inhibitor used to reduce intraocular pressure in patients with open angle glaucoma or ocular hypertension. | Prostaglandins, Synthetic |
| Piperaquine | 535.52 C29H32Cl2N6 |  | For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB11638. | Anti-Infective Agents / Antimalarials / Antiparasitic Agents / Antiparasitic Products, Insecticides and Repellents / Antiprotozoals / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (weak) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2E1 Inducers / Cytochrome P-450 CYP2E1 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring |
| Testosterone cypionate | 412.614 C27H40O3 |  | An androgen used to treat low or absent testosterone. | Anabolic Agents / Androgens / Delayed-Action Preparations |
| Testosterone enanthate | 400.594 C26H40O3 |  | An androgen used to treat low or absent testosterone. | Androgens |
| Testosterone undecanoate | 456.711 C30H48O3 |  | An androgen indicated for testosterone replacement therapy in adult males with primary hypogonadism and hypogonadotropic hypogonadism. | Androgens |
| Testosterone enantate benzilic acid hydrazone | 624.866 C40H52N2O4 |  | Not Annotated | Androstanes / Androstenes / Androstenols / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Steroids / Testosterone and derivatives / Testosterone Congeners |
| Ferric cation | 55.845 Fe |  | An iron supplement indicated in the treatment of iron deficiency anemia. | Parenteral Iron Replacement / Phosphate Binder |
| Estradiol acetate | 314.4186 C20H26O3 |  | An estrogen used to treat vasomotor symptoms and moderate to severe vulvar and vaginal atrophy from menopause. | Estrogens |
| Estradiol benzoate | 376.488 C25H28O3 |  | An estrogen indicated in combination with progesterone for the treatment of irregular menstruation. | Contraceptive Agents, Hormonal |
Displaying drugs 2451 - 2475 of 2778 in total